According to recent estimates from the World Health Organization, more than one in five people aged 15–49 live with genital herpes.

A phase 3 study demonstrated that ritlecitinib was effective and well tolerated in patients with alopecia areata and ≥ 25% ...

Fintel reports that on February 7, 2025, B of A Securities initiated coverage of Candel Therapeutics (NasdaqGM:CADL) with a ...

Cold sores can be a frustrating and uncomfortable experience, but they’re incredibly common and usually nothing to worry about health-wise. The small, fluid-filled blisters typically appear around the ...

Herpes Labialis Treatment Market. The global herpes labialis treatment market is on track for substantial growth, with a projected Compound Annual Growth Rate (CAGR) of 4.7% from ...

Basal cell carcinomas, the most common form of skin cancer, occur in chronically sun-exposed areas such as the face. Locally ...

NanoViricides, Inc. (NYSE American:NNVC) (the “Company”) today announced that it has engaged a Clinical Research Organization (CRO) to conduct a Phase II clinical trial advancing its broad-spectrum ...

A new study from the Hong Kong Children's Hospital reveals critical insights into the infection risks associated with ...

Adolore BioTherapeutics (”Adolore” or the “Company”), is developing intracellularly-delivered neuromodulators that naturally reduce neuronal excitability to restore balance to the PNS/CNS to treat the ...

Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...